{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:19:58Z","timestamp":1763702398001,"version":"3.45.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Angioimmunoblastic T cell lymphoma (AITL) is classified as a nodal T-cell lymphoma from T follicular helper(Tfh) cells. Dysfunctional Tfh cells can lead to abnormal B cell regulation and plasma cell differentiation in AITL. However, the coexistence of AITL with plasma cell tumors is exceedingly rare. Here, we report three patients diagnosed with AITL accompanied by monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and multiple myeloma (MM). The clinicopathologic findings, together with a review of previously reported cases, provide insight into the possible biological relationship between AITL and plasma-cell neoplasms. Epstein\u2013Barr virus (EBV) infection was detected in all cases, suggesting a potential\u2014though unproven\u2014association between EBV-driven immune dysregulation and plasma-cell proliferation. Case analysis showed that some monoclonal plasma cells originated from the interior of AITL, while others originated from the bone marrow. This indicated that the evolution of plasma cell tumors may arise from either the lymphoma microenvironment or the systemic immune status. In cases of coexistence of AITL and plasma cell tumors, the treatment containing anti-MM drugs such as lenalidomide was usually recommended and might bring therapeutic benefits. Careful identification of monoclonal plasma-cell populations is therefore important for accurate diagnosis and individualized management of AITL.<\/jats:p>","DOI":"10.3389\/fonc.2025.1705496","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:14:55Z","timestamp":1763702095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Angioimmunoblastic T-cell lymphoma with coexisting plasma cell tumors: three cases and review of the literature"],"prefix":"10.3389","volume":"15","author":[{"given":"Yulin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingshuo","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (Excluding anaplastic large-cell lymphoma): results from the non-hodgkin\u2019s lymphoma classification project","volume":"13","author":"R\u00fcdiger","year":"2002","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the groupe D\u2019etude des lymphomes de L\u2019adulte (Gela) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","author":"Lunning","year":"2017","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41389-020-00259-x","article-title":"New preclinical models for angioimmunoblastic T-cell lymphoma: filling the gap","volume":"9","author":"Mhaidly","year":"2020","journal-title":"Oncogenesis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-0837-8_12","article-title":"The role of inflammation in lymphoma","volume":"816","author":"Carbone","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: A multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06725.x","article-title":"Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of epstein-barr virus-infected cells in early cases","volume":"138","author":"Willenbrock","year":"2007","journal-title":"Br J Haematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcancer.2013.11.004","article-title":"The microenvironment in T-cell lymphomas: emerging themes","volume":"24","author":"Gaulard","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of pcr primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the biomed-2 concerted action bmh4-ct98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7660","article-title":"Diagnosis and management of monoclonal gammopathy and smoldering multiple myeloma","volume":"18","author":"Schmidt","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.10.083","article-title":"Development of T follicular helper cells and their role in disease and immune system","volume":"84","author":"Eivazi","year":"2016","journal-title":"BioMed Pharmacother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1105651","article-title":"Pathologic and molecular insights in nodal T-follicular helper cell lymphomas","volume":"13","author":"Marques-Piubelli","year":"2023","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.43.3797","article-title":"Angioimmunoblastic T-cell lymphoma partially obscured by an epstein-barr virus-negative clonal plasma cell proliferation","volume":"31","author":"Huppmann","year":"2013","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cancers13040610","article-title":"Comprehensive epstein-barr virus transcriptome by rna-sequencing in angioimmunoblastic T cell lymphoma (Aitl) and other lymphomas. Cancers (Basel)","volume":"13","author":"Bayda","year":"2021","journal-title":"Cancers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3390\/cancers14122899","article-title":"Epstein-barr virus (Ebv) is mostly latent and clonal in angioimmunoblastic T cell lymphoma (Aitl)","volume":"14","author":"Bahri","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3390\/v16040564","article-title":"Deciphering the role of epstein-Barr virus latent membrane protein 1 in immune modulation: A multifaced signalling perspective","volume":"16","author":"\u0160imi\u010di\u0107","year":"2024","journal-title":"Viruses"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-594689","article-title":"Epstein-barr virus lmp2a suppresses mhc class ii expression by regulating the B-cell transcription factors E47 and pu","volume":"125","author":"Lin","year":"2015","journal-title":"1. Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.virol.2016.10.015","article-title":"Epstein-barr virus latent membrane protein 2a (Lmp2a) enhances il-10 production through the activation of bruton\u2019s tyrosine kinase and stat3","volume":"500","author":"Incrocci","year":"2017","journal-title":"Virology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.12.8225","article-title":"Latent membrane protein 1 of ebv activates phosphatidylinositol 3-kinase to induce production of il-10","volume":"179","author":"Lambert","year":"2007","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00430-08","article-title":"Epstein-barr virus latent membrane protein 1 represses DNA repair through the pi3k\/akt\/foxo3a pathway in human epithelial cells","volume":"82","author":"Chen","year":"2008","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209840200","article-title":"Epstein-barr virus latent membrane protein 1 (Lmp1) activates the phosphatidylinositol 3-kinase\/akt pathway to promote cell survival and induce actin filament remodeling","volume":"278","author":"Dawson","year":"2003","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203327","article-title":"Epstein-barr virus ebna3c can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis","volume":"19","author":"Parker","year":"2000","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coviro.2017.07.017","article-title":"Epstein-barr virus: A master epigenetic manipulator","volume":"26","author":"Scott","year":"2017","journal-title":"Curr Opin Virol"},{"key":"B24","article-title":"A rare episode of extensive bone marrow necrosis in a chemotherapy-na\u00efve patient with multiple myeloma exhibiting tp53 and tet2 mutations","volume":"50","author":"Jeon","year":"2020","journal-title":"Ann Clin Lab Sci"},{"key":"B25","article-title":"Effective treatment with venetoclax and hypomethylating agents for the coexistence of multiple myeloma and acute myeloid leukemia: A case report and literature review","volume":"54","author":"Chen","year":"2024","journal-title":"Ann Clin Lab Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001636","article-title":"Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms","volume":"4","author":"Lewis","year":"2020","journal-title":"Blood Adv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.3390\/cancers14225699","article-title":"Targeting tet2 as a therapeutic approach for angioimmunoblastic T cell lymphoma","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3892\/ol.2023.13836","article-title":"Misdiagnosis of angioimmunoblastic T\u2212Cell lymphoma: A case report","volume":"25","author":"Li","year":"2023","journal-title":"Oncol Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1177590","article-title":"Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances","volume":"13","author":"Lage","year":"2023","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-19-0343","article-title":"Il6 promotes a stat3-prl3 feedforward loop via shp2 repression in multiple myeloma","volume":"79","author":"Chong","year":"2019","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1048","article-title":"Interleukin-6-dependent gene expression profiles in multiple myeloma ina-6 cells reveal a bcl-2 family-independent survival pathway closely associated with stat3 activation","volume":"103","author":"Brocke-Heidrich","year":"2004","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.036","article-title":"Il-6-induced bcl6 variant 2 supports il-6-dependent myeloma cell proliferation and survival through stat3","volume":"337","author":"Tsuyama","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1243997","article-title":"Molecular and immunological mechanisms of clonal evolution in multiple myeloma","volume":"14","author":"Forster","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00432-024-05702-9","article-title":"Role of plasma ebv-DNA load and eber status on newly diagnosed peripheral T-cell lymphoma","volume":"150","author":"Chen","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e95367","DOI":"10.1172\/jci.insight.95367","article-title":"Monoclonal igg in mgus and multiple myeloma targets infectious pathogens","volume":"2","author":"Bosseboeuf","year":"2017","journal-title":"JCI Insight"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/cancers12051254","article-title":"Characteristics of mgus and multiple myeloma according to the target of monoclonal immunoglobulins, glucosylsphingosine, or epstein-barr virus ebna-1","volume":"12","author":"Bosseboeuf","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04110-6","article-title":"Unique evolution of angioimmunoblastic T cell lymphoma to epstein-barr virus-positive plasma cell myeloma","volume":"99","author":"Chan","year":"2020","journal-title":"Ann Hematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.235.283","article-title":"Angioimmunoblastic T-cell lymphoma with coexisting plasma cell myeloma: A case report and review of the literature","volume":"235","author":"Xu","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12185-018-02587-6","article-title":"A case of aitl complicated by ebv-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide","volume":"109","author":"Kishimoto","year":"2019","journal-title":"Int J Hematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1997.tb02309.x","article-title":"An autopsy case of angioimmunoblastic T-cell lymphoma with a high content of epithelioid cells in the lymph node: immunohistochemical and genomic analyses","volume":"24","author":"Morita","year":"1997","journal-title":"J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2810","article-title":"T-cell lymphoma with poems syndrome","volume":"9","author":"Zou","year":"2015","journal-title":"Oncol Lett"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.03.084","article-title":"Acute renal failure due to igm-lambda glomerular thrombi and mpgn-like lesions in a patient with angioimmunoblastic T-cell lymphoma","volume":"48","author":"Miura","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12814","article-title":"Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression","volume":"43","author":"Su\u00e1rez","year":"2016","journal-title":"J Cutan Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1309\/6utx-gvc0-12nd-jjeu","article-title":"Epstein-barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified","volume":"117","author":"Zettl","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3180339f18","article-title":"Epstein-barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: A phenomenon with distinctive clinicopathologic features","volume":"31","author":"Balagu\u00e9","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3490","article-title":"A case of cd10-negative angioimmunoblastic T cell lymphoma with leukemic change and increased plasma cells mimicking plasma cell leukemia: A case report","volume":"10","author":"Adachi","year":"2015","journal-title":"Oncol Lett"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.03.014","article-title":"Angioimmunoblastic T-cell lymphoma presenting with extensive marrow plasmacytosis and hypergammaglobulinaemia: A diagnostic challenge","volume":"50","author":"Sachdev","year":"2018","journal-title":"Pathology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26878","article-title":"Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia","volume":"98","author":"Mejia Saldarriaga","year":"2023","journal-title":"Am J Hematol"},{"key":"B49","article-title":"Peripheral blood polyclonal plasmacytosis mimicking plasma cell leukemia in patients with angioimmunoblastic T-cell lymphoma: report of 3 cases and review of the literature","volume":"4","author":"Ahsanuddin","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000096894","article-title":"Angioimmunoblastic T-cell lymphoma with polyclonal proliferation of plasma cells in peripheral blood and marrow","volume":"117","author":"Yamane","year":"2007","journal-title":"Acta Haematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.6121","article-title":"Angioimmunoblastic T-cell lymphoma initially presenting with replacement of bone marrow and peripheral plasmacytosis","volume":"46","author":"Sakai","year":"2007","journal-title":"Intern Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1411-z","article-title":"Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis","volume":"98","author":"Nagoshi","year":"2013","journal-title":"Int J Hematol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9951122","article-title":"The early diagnostic dilemma in angioimmunoblastic T cell lymphoma with excessive plasma cells proliferation","volume":"2021","author":"Wang","year":"2021","journal-title":"Case Rep Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100744","article-title":"Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity","volume":"3","author":"Mirlekar","year":"2022","journal-title":"Cell Rep Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1545","article-title":"Multiple myeloma cells expressing low levels of cd138 have an immature phenotype and reduced sensitivity to lenalidomide","volume":"41","author":"Kawano","year":"2012","journal-title":"Int J Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13283","article-title":"Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response","volume":"108","author":"Tahara","year":"2017","journal-title":"Cancer Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1309\/5el22bh45phupm8p","article-title":"Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma","volume":"127","author":"Seegmiller","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609052420","article-title":"The neural cell adhesion molecule ncam in multiple myeloma","volume":"20","author":"Kaiser","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(18)30131-5","article-title":"Lenalidomide in combination with R-chop (R2-chop) as first-line treatment of patients with high tumour burden follicular lymphoma: A single-arm, open-label, phase 2 study","volume":"5","author":"Tilly","year":"2018","journal-title":"Lancet Haematol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003081","article-title":"Integrative analysis of a phase 2 trial combining lenalidomide with chop in angioimmunoblastic T-cell lymphoma","volume":"5","author":"Lemonnier","year":"2021","journal-title":"Blood Adv"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18885","article-title":"Final results of a phase ii study of choep plus lenalidomide as initial therapy for patients with stage ii-iv peripheral T-cell lymphoma","volume":"202","author":"Stuver","year":"2023","journal-title":"Br J Haematol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12678","article-title":"Bortezomib, lenalidomide and dexamethasone (Vrd) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma","volume":"164","author":"Chaoui","year":"2014","journal-title":"Br J Haematol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.04.029","article-title":"A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-hodgkin lymphoma: the expect trial","volume":"49","author":"Morschhauser","year":"2013","journal-title":"Eur J Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.06.003","article-title":"Bortezomib in combination with chop as first-line treatment for patients with stage iii\/iv peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial","volume":"48","author":"Kim","year":"2012","journal-title":"Eur J Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003774","article-title":"Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma","volume":"5","author":"M\u00e9nard","year":"2021","journal-title":"Blood Adv"},{"key":"B66","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1158\/2326-6066.Cir-15-0291","article-title":"Lenalidomide induces interleukin-21 production by T cells and enhances il21-mediated cytotoxicity in chronic lymphocytic leukemia B cells","volume":"4","author":"Browning","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1182\/hematology.2024000670","article-title":"The role of stem cell transplant (Auto and allo) in ptcl and ctcl","volume":"2024","author":"Dreger","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01545-w","article-title":"Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory ptcl-nos or aitl","volume":"36","author":"Kameda","year":"2022","journal-title":"Leukemia"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1705496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:14:58Z","timestamp":1763702098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1705496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":68,"alternative-id":["10.3389\/fonc.2025.1705496"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1705496","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1705496"}}